|
|
|
|
|
|
Sponsored by: |
Genentech |
Information provided by: | Genentech |
ClinicalTrials.gov Identifier: | NCT00105456 |
This is a prospective observational cohort study designed to describe effectiveness and safety (treatment outcomes and clinically significant cardiac adverse events, respectively) in patients with HER2-positive metastatic breast cancer.
Condition | Phase |
Breast Cancer |
Phase IV |
Genetics Home Reference related topics: | breast cancer |
MedlinePlus related topics: | Breast Cancer Cancer |
Study Type: | Observational |
Study Design: | Natural History, Longitudinal, Defined Population, Prospective Study |
Official Title: | registHER: An Observational Cohort Study of Patients With HER2 Positive Metastatic Breast Cancer |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | H2757n |
First Received: | March 14, 2005 |
Last Updated: | March 9, 2006 |
ClinicalTrials.gov Identifier: | NCT00105456 |
Health Authority: | United States: Institutional Review Board |
|
|
|